---
title: 'Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate
  mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate
  combinations as graft-versus-host disease prophylaxis post allogeneic stem cell
  transplantation from sibling and unrelated donors in patients with acute myeloid
  leukemia: a study on behalf of the Acute Leukemia Working Party of the European
  Society for Blood and Marrow Transplantation'
date: '2024-04-13'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38615143/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240414191153&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Post-transplant cyclophosphamide plus calcineurin inhibitor (CNI)(tacrolimus
  or cyclosporine A) plus mycophenolate mofetil (PTCy/TAC or CSA/MMF) and anti-thymocyte
  globulin plus CNI (tacrolimus or cyclosporine A) plus methotrexate (ATG/TAC or CSA/MTX)
  are common graft-versus-host disease (GVHD) prophylaxis regimens. We compared the
  two regimens in patients with acute myeloid leukemia (AML) undergoing allogeneic
  transplantation from matched siblings or unrelated donors. 402 received PTCy/TAC
  ...
disable_comments: true
---
Post-transplant cyclophosphamide plus calcineurin inhibitor (CNI)(tacrolimus or cyclosporine A) plus mycophenolate mofetil (PTCy/TAC or CSA/MMF) and anti-thymocyte globulin plus CNI (tacrolimus or cyclosporine A) plus methotrexate (ATG/TAC or CSA/MTX) are common graft-versus-host disease (GVHD) prophylaxis regimens. We compared the two regimens in patients with acute myeloid leukemia (AML) undergoing allogeneic transplantation from matched siblings or unrelated donors. 402 received PTCy/TAC ...